Atlas Trials

Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line

Clinical trial NCT02187042 · COMPLETED

Trial details

NCT number
NCT02187042
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic/Advanced Renal Cell Carcinoma
Start date
2015-10-07
Primary completion
2018-07-25
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.